Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Panbela Therapeutics Inc
PBLA
Healthcare
Biotechnology
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is involved in enrolling patients in its randomized double-blind placebo-controlled clinical trial for the treatment of pancreatic cancer. The Company's lead assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X). Ivospemin is a polyamine analog designed to...
induce polyamine metabolic inhibition (PMI). Flynpovi is a combination of CPP-1X (eflornithine) and sulindac. It has a dual mechanism of action whereby it suppresses the synthesis of new polyamines and increases the export and catabolism of polyamines from the diet and microbiome. Eflornithine is being developed as a single-agent tablet or high-dose powder sachet for several indications, including prevention of gastric cancer, treatment of neuroblastoma and recent onset Type 1 diabetes metastatic castration-resistant prostate cancer, and STK-11 mutant NSCLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:PBLA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 01, 2023 8:30am
New Press Release - Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
MINNEAPOLIS, March 01, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for SBP-101, a proprietary polyamine analogue, has...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 13, 2023 8:30am
New Press Release - Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that, primarily as a result of the January 30...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 31, 2023 10:13am
PBLA.....Vols are increasing
Price is also Cheers to the Bulls !!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 5:07pm
PBLA .... Worth a repeat !!!
PBLA ..... this is starting to look more inviting ; ) If this can break the H.O.D at $1.57....the next target would be $1.74 and then my Big Fat Blue line is at $1.77 Above that it is a big gap
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 5:06pm
PBLA....... Ka Booom in AH
over $1.90
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 5:01pm
PBLA..... Up in After Hours Trading ; )
Rockin at $1.88 Panbela...... Good Bread...Good God lets eat ; ) Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 4:02pm
PBLA..... Nice high close ; )
Better than a poke in the eye with a sharp stick Panbela.......Spanish translation is Good Bread Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 1:39pm
PBLA ....is it time to start the "drumroll" ???
Ya just never know......but it's looking good ; ) $1.55
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 12:30pm
PBLA ..... this is starting to look more inviting ; )
If this can break the H.O.D at $1.57....the next target would be $1.74 and then my Big Fat Blue line is at $1.77 Above that it is a big gap up to $2.50 ; ) Yes ...it is attainable Watch for a
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 30, 2023 12:02pm
PBLA ....post RS now and P.O at $2.25
I'd say this is worth a shot here at $1.48 On watch....no position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 17, 2023 10:38am
PBLA ..... RS last week.... 1.1 million shs o/s....on watch
Panbela Announces 1-for-40 Reverse Stock Split effective January 13, 2023 2023-01-12 08:00 ET - News Release MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- -- Panbela Therapeutics,
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 22, 2022 2:09pm
PBLA ..... I'm no chaser....
So neither r u
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 22, 2022 2:07pm
PBLA
Dang ... I missed this one
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year
Discovery of Large Near Surface EM Conductor Southeast of Cam Copper Mine